[go: up one dir, main page]

CN101891665A - (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method - Google Patents

(3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method Download PDF

Info

Publication number
CN101891665A
CN101891665A CN2009100518202A CN200910051820A CN101891665A CN 101891665 A CN101891665 A CN 101891665A CN 2009100518202 A CN2009100518202 A CN 2009100518202A CN 200910051820 A CN200910051820 A CN 200910051820A CN 101891665 A CN101891665 A CN 101891665A
Authority
CN
China
Prior art keywords
compound
formula
acid
chloride
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2009100518202A
Other languages
Chinese (zh)
Other versions
CN101891665B (en
Inventor
张福利
梁小敏
王环
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN 200910051820 priority Critical patent/CN101891665B/en
Publication of CN101891665A publication Critical patent/CN101891665A/en
Application granted granted Critical
Publication of CN101891665B publication Critical patent/CN101891665B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供了(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮及其制备方法。本发明还提供了其中间体(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺(I)和(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮(II)及其制备方法。本发明的方法原料价廉易得,收率高,操作简便,对环境友好,易实现规模化生产。

Figure 200910051820.2_AB_0
The invention provides (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and a preparation method thereof. The present invention also provides its intermediate (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutyramide (I) and (3S, 4S)-1-benzidine Base-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone (II) and its preparation method. The method of the invention has the advantages of cheap and easy-to-obtain raw materials, high yield, simple operation, environmental friendliness and easy realization of large-scale production.
Figure 200910051820.2_AB_0

Description

(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮及其制备方法 (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method

技术领域technical field

本发明涉及药物化学领域,具体涉及化合物(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮及其制备方法,本发明还涉及其中间体(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺和(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮及其制备方法。The invention relates to the field of medicinal chemistry, in particular to the compound (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and a preparation method thereof. Involving its intermediates (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutanamide and (3S, 4S)-1-benzhydryl-3-((R )-1-hydroxyethyl)-4-acetyl-2-azetidinone and its preparation method.

背景技术Background technique

青霉烯和碳青霉烯类抗生素是上世纪70年代发展起来的非典型β-内酰胺类抗生素。其抗菌作用强,对β-内酰胺酶稳定。在目前的临床抗感染治疗,尤其是对耐药菌引起的感染治疗中,占有重要的地位。Penem and carbapenem antibiotics are atypical β-lactam antibiotics developed in the 1970s. It has strong antibacterial effect and is stable to β-lactamase. It occupies an important position in the current clinical anti-infection treatment, especially in the treatment of infections caused by drug-resistant bacteria.

(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮(简称4-AA)是制备青霉烯和碳青霉烯类抗生素的关键中间体,其结构式如式(VI)所示:(3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxy-2-azetidinone (4-AA for short) is the preparation of Penicillium The key intermediate of alkene and carbapenem antibiotics, its structural formula is as shown in formula (VI):

Figure B2009100518202D0000011
Figure B2009100518202D0000011

4-AA的合成报道很多,J Chem Soc Chem Com,1992,662-664;J OrgChem,1992,57:4232-4237;Chem Pharm Bull 1992,40:1094-1097;Tetrahedron Lett,1982,23:2293-2296;Tetrahedron Lett,1986,27:4961-4964;Tetrahedron Lett,1988,29:1409-1412;Tetrahedron Lett,1998,39:7779-7782;WO9807691;EP0774463;EP167154;JP5239019;JP4173776;JP4173795;JP2134349都报道了4-AA的制备方法。There are many reports on the synthesis of 4-AA, J Chem Soc Chem Com, 1992, 662-664; J OrgChem, 1992, 57: 4232-4237; Chem Pharm Bull 1992, 40: 1094-1097; Tetrahedron Lett, 1982, 23: 2293 -2296;Tetrahedron Lett,1986,27:4961-4964;Tetrahedron Lett,1988,29:1409-1412;Tetrahedron Lett,1998,39:7779-7782;WO9807691;EP0774463;EP167154;JP5239019;JP4173776;JP4173795;JP2134349都The preparation method of 4-AA was reported.

4-AA分子中含有3个手性中心,合成难度大。如何引入3个手性中心,立体选择性的形成β-内酰胺环是合成的关键所在。The 4-AA molecule contains three chiral centers, which is difficult to synthesize. How to introduce three chiral centers and stereoselectively form the β-lactam ring is the key to the synthesis.

采用天然手性源L-苏氨酸为起始原料引入2个手性中心,再在后续反应中构建第三个手性中心,这种方法已报道的有以下几种:The natural chiral source L-threonine is used as the starting material to introduce two chiral centers, and then the third chiral center is constructed in the subsequent reaction. This method has been reported as follows:

J Am Chem Soc,1985,1438-1439J Am Chem Soc, 1985, 1438-1439

Figure B2009100518202D0000021
Figure B2009100518202D0000021

该路线需经过不稳定的2,3-环氧丁酸中间体,并且形成β-内酰胺环的立体选择性不高,脱保护要使用对环境有害的硝酸铈铵,得到的苯甲酰氧化合物还需要与醋酸钾反应才能得到4-AA。This route needs to pass through the unstable 2,3-epoxybutyric acid intermediate, and the stereoselectivity of forming the β-lactam ring is not high, and the deprotection needs to use cerium ammonium nitrate which is harmful to the environment, and the obtained benzoyloxy The compound also needs to be reacted with potassium acetate to give 4-AA.

(2)Tetrahedron,1984,1795-1802(2) Tetrahedron, 1984, 1795-1802

Figure B2009100518202D0000022
Figure B2009100518202D0000022

该路线避免了经过不稳定的2,3-环氧丁酸中间体,但是缩合形成酰胺化合物用到价格较贵的DCC,形成β-内酰胺环的收率较低。路线中还用到了剧毒物质二甲基镉。This route avoids the unstable 2,3-epoxybutyric acid intermediate, but the condensation to form the amide compound uses more expensive DCC, and the yield of the β-lactam ring is low. The highly toxic substance dimethyl cadmium is also used in the route.

(3)Eur J Org Chem,2006,3755-3766(3) Eur J Org Chem, 2006, 3755-3766

Figure B2009100518202D0000031
Figure B2009100518202D0000031

与方法(1)和(2)相比,方法(3)原料易得,操作简便,但是存在以下问题:1.起始原料需用到甲基环丙基酮,市场不易得。2.由于脱保护产物水溶性大,与对甲苯磺酸一起溶于水中,不易分离。3.得到的环丙甲酰基化合物必须与醋酸盐再经过一步转化才能得到4-AA。Compared with methods (1) and (2), method (3) has easy-to-obtain raw materials and is easy to operate, but has the following problems: 1. The starting material needs to use methyl cyclopropyl ketone, which is not easily available in the market. 2. Due to the high water solubility of the deprotected product, it is soluble in water together with p-toluenesulfonic acid and is not easy to separate. 3. The obtained cyclopropylformyl compound must be transformed with acetate to obtain 4-AA.

发明内容Contents of the invention

为了改进(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮的合成工艺,在兼顾成本和安全操作的情况下提高反应收率,提出了本发明。In order to improve the synthetic technique of (3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxy-2-azetidinone, taking into account cost and In order to improve the reaction yield under the condition of safe operation, the present invention is proposed.

根据本发明的第一个方面,其提供了一种具有如下结构式的式(III)化合物[(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮]:According to the first aspect of the present invention, it provides a compound of formula (III) [(3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2 having the following structural formula -azetidinone]:

Figure B2009100518202D0000032
Figure B2009100518202D0000032

式(III)化合物可以用作合成(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮(4-AA)的中间体。合成路线如下:Formula (III) compound can be used as synthetic (3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxyl group-2-azetidinone ( 4-AA) intermediates. The synthetic route is as follows:

根据本发明的技术方案,上述(III)化合物是以下列两种化合物作为关键中间体制备得到的:According to the technical scheme of the present invention, the above-mentioned (III) compound is prepared by using the following two compounds as key intermediates:

具有如下结构式(I)的化合物[(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺]:A compound [(2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutyramide] with the following structural formula (I):

Figure B2009100518202D0000041
Figure B2009100518202D0000041

以及,as well as,

具有如下结构式的式(II)化合物[(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮]:A compound of formula (II) having the following structural formula [(3S,4S)-1-benzhydryl-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone] :

Figure B2009100518202D0000042
Figure B2009100518202D0000042

上述式(I)化合物和式(II)化合物是制备式(III)化合物的关键中间体。The above-mentioned compound of formula (I) and compound of formula (II) are key intermediates for preparing the compound of formula (III).

根据本发明的第二个方面,其还提供了一种制备上述的式(III)化合物的方法,其包括以下步骤:According to a second aspect of the present invention, it also provides a method for preparing the above-mentioned compound of formula (III), which comprises the following steps:

a)将具有如下结构式的式(IV)化合物(2R,3R)-2,3-环氧丁酸钠在酰氯活化下,加入碱在有机溶剂中和式(V)化合物1-二苯甲基胺基-2-丙酮进行缩合,得到式(I)化合物;a) The formula (IV) compound (2R, 3R)-2,3-epoxybutyric acid sodium with the following structural formula is activated by acid chloride, and a base is added in an organic solvent to neutralize the formula (V) compound 1-benzhydryl Amino-2-propanone is condensed to obtain a compound of formula (I);

b)使式(I)化合物在碱的催化下在有机溶剂中闭环,得到式(II)化合物;b) ring-closing the compound of formula (I) in an organic solvent under the catalysis of a base to obtain the compound of formula (II);

Figure B2009100518202D0000044
Figure B2009100518202D0000044

(I)        (II)(I) (II)

c)使式(II)化合物在卤化剂和硅胶或者质子酸作用下在有机溶剂中脱除二苯甲基保护基,得到式(III)化合物。c) removing the benzhydryl protecting group from the compound of formula (II) in an organic solvent under the action of a halogenating agent and silica gel or protonic acid to obtain the compound of formula (III).

其中步骤a)本发明将活化试剂缓慢滴加入环氧丁酸钠(IV)与合适溶剂组成的悬浊液中,转化为环氧丁酰氯后再加入碱和化合物(V)反应生成式(I)化合物。合适的活化试剂酰氯选自一种或多种下列物质:乙酰氯、二氯亚砜、草酰氯、特戊酰氯、氯甲酸异丁酯、2,4,6-三氯苯甲酰氯。合适的碱选自一种或多种下列物质:二甲胺、二乙胺、二异丙胺、N-甲基苯胺、哌啶、吡咯、吡啶、吗啉、二异丙基乙胺、三乙胺、N,N-二甲基苯胺、N-乙基哌啶、N-甲基吗啉、N-乙基吡咯烷、N,N,N’N’-四甲基乙二胺。合适的溶剂选自一种或多种下列物质:卤代烃类、烷烃、酯类、乙醚、异丙醚、甲基叔丁基醚、四氢呋喃、苯、甲苯、二甲苯、乙腈。其中,化合物(V)的用量是化合物(IV)的1~2倍,活化试剂的用量是化合物(IV)的1~2倍,加入的碱作为缚酸剂与反应中产生的氯化氢反应,促使反应转化。碱的用量是化合物(IV)的1~5倍。反应温度为-50℃~40℃,优选为-20~25℃。Wherein in step a) the present invention slowly adds the activating reagent dropwise into the suspension composed of sodium epoxybutyrate (IV) and a suitable solvent, converts it into epoxybutyryl chloride and then adds alkali and compound (V) to react to generate formula (I ) compound. Suitable activating reagents are acid chlorides selected from one or more of the following: acetyl chloride, thionyl chloride, oxalyl chloride, pivaloyl chloride, isobutyl chloroformate, 2,4,6-trichlorobenzoyl chloride. Suitable bases are selected from one or more of the following: dimethylamine, diethylamine, diisopropylamine, N-methylaniline, piperidine, pyrrole, pyridine, morpholine, diisopropylethylamine, triethylamine Amine, N,N-dimethylaniline, N-ethylpiperidine, N-methylmorpholine, N-ethylpyrrolidine, N,N,N'N'-tetramethylethylenediamine. Suitable solvents are selected from one or more of the following: halogenated hydrocarbons, alkanes, esters, diethyl ether, isopropyl ether, methyl tert-butyl ether, tetrahydrofuran, benzene, toluene, xylene, acetonitrile. Wherein, the amount of compound (V) is 1 to 2 times that of compound (IV), and the amount of activating reagent is 1 to 2 times that of compound (IV), and the added base acts as an acid-binding agent to react with the hydrogen chloride produced in the reaction to promote reaction conversion. The amount of base used is 1 to 5 times that of compound (IV). The reaction temperature is -50°C to 40°C, preferably -20 to 25°C.

其中步骤b)本发明将式(I)化合物在碱的催化下在有机溶剂中闭环,得到式化合物(II),合适的碱选自一种或多种下列物质:六甲基二硅胺锂,六甲基二硅胺钠,二异丙胺锂。合适的溶剂选自一种或多种下列物质:卤代烃、烷烃、酯类、四氢呋喃、乙醚、异丙醚、甲基叔丁基醚、四氢呋喃、苯、甲苯、二甲苯、乙腈。其中,化合物(I)在碱的作用下生成烯醇式进而进攻环氧上的碳,闭环生成化合物(II)。碱的用量是式(I)化合物的1~2倍。反应温度-20℃~40℃,优选为-20~25℃。Wherein step b) in the present invention, the compound of formula (I) is ring-closed in an organic solvent under the catalysis of a base to obtain the compound of formula (II), and the suitable base is selected from one or more of the following substances: lithium hexamethyldisilazide , Sodium Hexamethyldisilazide, Lithium Diisopropylamide. Suitable solvents are selected from one or more of the following: halogenated hydrocarbons, alkanes, esters, tetrahydrofuran, diethyl ether, isopropyl ether, methyl tert-butyl ether, tetrahydrofuran, benzene, toluene, xylene, acetonitrile. Among them, the compound (I) generates an enol formula under the action of a base and then attacks the carbon on the epoxy, and the ring is closed to generate the compound (II). The amount of base used is 1 to 2 times that of the compound of formula (I). The reaction temperature is -20°C to 40°C, preferably -20°C to 25°C.

其中步骤c)本发明将式(II)化合物溶于合适的有机溶剂中,在卤化剂的作用下生成卤化物,再与水反应转化为羟基化合物,在硅胶或者质子酸的作用下脱除保护基得到式(III)化合物。合适卤化剂选自一种或多种下列物质:N-氯代丁二酰亚胺、N-溴代丁二酰亚胺。优选为N-溴代丁二酰亚胺。合适的溶剂选自一种或多种下列物质:脂肪酮、芳香酮、烷烃、卤代烷、乙腈、四氢呋喃、乙醚,异丙醚、甲基叔丁基醚、苯、甲苯、二甲苯等。质子酸为无机酸、有机酸,例如,其可以选自一种或多种下列酸:盐酸,硫酸,硝酸,磷酸,对甲苯磺酸,乙酸,甲酸等。卤化剂的用量是式(II)化合物的1~2倍,硅胶或者质子酸的用量是式(II)化合物的1~5倍。反应温度为0℃~100℃,优选为20~80℃。Wherein step c) the present invention dissolves the compound of formula (II) in a suitable organic solvent, generates a halide under the action of a halogenating agent, then reacts with water and converts it into a hydroxyl compound, and deprotects it under the action of silica gel or protonic acid group to obtain the compound of formula (III). Suitable halogenating agents are selected from one or more of the following: N-chlorosuccinimide, N-bromosuccinimide. N-bromosuccinimide is preferred. Suitable solvents are selected from one or more of the following: aliphatic ketones, aromatic ketones, alkanes, haloalkanes, acetonitrile, tetrahydrofuran, diethyl ether, isopropyl ether, methyl tert-butyl ether, benzene, toluene, xylene, and the like. Protic acid is inorganic acid, organic acid, for example, it can be selected from one or more of the following acids: hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, p-toluenesulfonic acid, acetic acid, formic acid and the like. The amount of the halogenating agent is 1-2 times that of the compound of formula (II), and the amount of silica gel or protonic acid is 1-5 times that of the compound of formula (II). The reaction temperature is 0°C to 100°C, preferably 20 to 80°C.

综上所述,本发明的起始原料可用价廉易得的L-苏氨酸和氯丙酮合成得到,脱除二苯甲基保护基时不使用PTSA等酸而采用硅胶,反应温和,后处理简单,产物易纯化。并且最后不需与醋酸盐反应而直接得到4-AA,路线简练。In summary, the starting materials of the present invention can be synthesized from cheap and easy-to-obtain L-threonine and chloroacetone. When removing the benzhydryl protecting group, instead of using acids such as PTSA, silica gel is used, and the reaction is mild. The treatment is simple and the product is easy to purify. And in the end, 4-AA can be directly obtained without reacting with acetate, and the route is concise.

具体实施方式Detailed ways

下面结合实施例对本发明作进一步阐述,但这些实施例不对本发明构成任何限制。The present invention will be further described below in conjunction with examples, but these examples do not constitute any limitation to the present invention.

实施例1:(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺(式(I)化合物)的制备Embodiment 1: the preparation of (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutanamide (formula (I) compound)

在一装有磁力搅拌机、温度计的250mL四口圆底烧瓶中,加入(2R,3R)-2,3-环氧丁酸钠7.9g,四氢呋喃100mL。冷却至-15℃后,滴加草酰氯3.7mL,在该温度下搅拌2小时,加入无水吡啶5.3mL,1-二苯甲基胺基-2-丙酮6.4g,搅拌1小时后升至室温继续搅拌2小时,加入100mL乙酸乙酯,5%碳酸氢钠溶液洗涤,分液后有机相用盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(I)7.2g,收率85.6%。In a 250 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 7.9 g of sodium (2R,3R)-2,3-epoxybutyrate and 100 mL of tetrahydrofuran. After cooling to -15°C, add 3.7 mL of oxalyl chloride dropwise, stir at this temperature for 2 hours, add 5.3 mL of anhydrous pyridine, 6.4 g of 1-benzhydrylamino-2-propanone, stir for 1 hour and then rise to Stirring was continued at room temperature for 2 hours, 100 mL of ethyl acetate was added, washed with 5% sodium bicarbonate solution, the organic phase was washed with brine after liquid separation, dried over anhydrous magnesium sulfate, filtered, and the solvent was evaporated, and the compound (I) was obtained by silica gel column chromatography 7.2 g, yield 85.6%.

MS:324.2(M+H);MS: 324.2 (M+H);

1HNMR:(400MHz,CDCl3)1.18(3H,m),2.13(3H,s),2.93(1H,m),3.47(1H,m),4.38(1H,s),6.16(1H,s),7.10-7.33(10H,m)。 1 HNMR: (400MHz, CDCl 3 ) 1.18(3H, m), 2.13(3H, s), 2.93(1H, m), 3.47(1H, m), 4.38(1H, s), 6.16(1H, s) , 7.10-7.33 (10H, m).

实施例2:(2R,3R)-N-二苯甲基-N-(2-氧代丙基)环氧丁酰胺(式(I)化合物)的制备Embodiment 2: the preparation of (2R, 3R)-N-benzhydryl-N-(2-oxopropyl) epoxybutyramide (formula (I) compound)

在一装有磁力搅拌机、温度计的250mL四口圆底烧瓶中,加入(2R,3R)-2,3-环氧丁酸钠7.9g,二氯甲烷100mL。冷却至-20℃后,滴加二氯亚砜4.9g,在该温度下搅拌2小时,加入三乙胺10.5g,1-二苯甲基胺基-2-丙酮6.4g,搅拌1小时后升温至回流反应2小时,加入100mL乙酸乙酯,5%碳酸氢钠溶液洗涤,分液后有机相用盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(I)7.2g,收率82.0%。In a 250 mL four-necked round bottom flask equipped with a magnetic stirrer and a thermometer, 7.9 g of sodium (2R,3R)-2,3-epoxybutyrate and 100 mL of dichloromethane were added. After cooling to -20°C, add 4.9 g of thionyl chloride dropwise, stir at this temperature for 2 hours, add 10.5 g of triethylamine, 6.4 g of 1-benzhydrylamino-2-propanone, and stir for 1 hour Heat up to reflux reaction for 2 hours, add 100mL ethyl acetate, wash with 5% sodium bicarbonate solution, wash the organic phase with brine after liquid separation, dry over anhydrous magnesium sulfate, evaporate the solvent after filtration, and obtain compound (I )7.2g, yield 82.0%.

MS:324.2(M+H);MS: 324.2 (M+H);

1HNMR:(400MHz,CDCl3)1.18(3H,m),2.13(3H,s),2.93(1H,m),3.47(1H,m),4.38(1H,s),6.16(1H,s),7.10-7.33(10H,m)。 1 HNMR: (400MHz, CDCl 3 ) 1.18(3H, m), 2.13(3H, s), 2.93(1H, m), 3.47(1H, m), 4.38(1H, s), 6.16(1H, s) , 7.10-7.33 (10H, m).

实施例3:(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮(式(II)化合物)的制备Example 3: (3S, 4S)-1-benzhydryl-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone (compound of formula (II)) preparation of

在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(I)化合物7.0g,二氯甲烷250mL。冷却至-20℃后,滴加LDA(1mol/L)26.4mL,滴加完毕升温至回流反应3小时,加入1N HCl 30mL,乙酸乙酯150mL,分液后有机相用5%碳酸氢钠溶液洗涤,盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(II)5.4g,收率77.4%。In a 500 mL four-necked round bottom flask equipped with a magnetic stirrer and a thermometer, 7.0 g of the compound of formula (I) and 250 mL of dichloromethane were added. After cooling to -20°C, add LDA (1mol/L) 26.4mL dropwise, heat up to reflux for 3 hours after the dropwise addition, add 1N HCl 30mL, ethyl acetate 150mL, and use 5% sodium bicarbonate solution for the organic phase after liquid separation Washing, washing with brine, drying over anhydrous magnesium sulfate, filtering and distilling off the solvent, silica gel column chromatography to obtain compound (II) 5.4g, yield 77.4%.

MS:324.2(M+H),346(M+Na)MS: 324.2(M+H), 346(M+Na)

1HNMR:(400MHz,CDCl3)1.28(3H,m),1.80(3H,s),2.96(1H,m),4.24(1H,m),4.56(1H,s),5.90(1H,s),7.25-7.33(10H,m) 1 HNMR: (400MHz, CDCl 3 ) 1.28(3H, m), 1.80(3H, s), 2.96(1H, m), 4.24(1H, m), 4.56(1H, s), 5.90(1H, s) , 7.25-7.33 (10H, m)

实施例4:(3S,4S)-1-二苯甲基-3-((R)-1-羟基乙基)-4-乙酰基-2-氮杂环丁酮(式(II)化合物)的制备Example 4: (3S, 4S)-1-benzhydryl-3-((R)-1-hydroxyethyl)-4-acetyl-2-azetidinone (compound of formula (II)) preparation of

在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(I)化合物7.0g,四氢呋喃250mL。冷却至-15℃后,滴加LiHMDS(1mol/L)26.4mL,滴加完毕升至室温反应3小时,加入1N HCl30mL,乙酸乙酯150mL,分液后有机相用5%碳酸氢钠溶液洗涤,盐水洗涤,无水硫酸镁干燥,过滤后蒸除溶剂,硅胶柱层析得到化合物(II)5.6g,收率80.3%。In a 500 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 7.0 g of the compound of formula (I) and 250 mL of tetrahydrofuran. After cooling to -15°C, add LiHMDS (1mol/L) 26.4mL dropwise, rise to room temperature and react for 3 hours after the dropwise addition, add 1N HCl30mL, ethyl acetate 150mL, and wash the organic phase with 5% sodium bicarbonate solution after liquid separation , washed with brine, dried over anhydrous magnesium sulfate, filtered, and evaporated to remove the solvent. Silica gel column chromatography gave 5.6 g of compound (II), with a yield of 80.3%.

MS:324.2(M+H),346(M+Na)MS: 324.2(M+H), 346(M+Na)

1HNMR:(400MHz,CDCl3)1.28(3H,m),1.80(3H,s),2.96(1H,m),4.24(1H,m),4.56(1H,s),5.90(1H,s),7.25-7.33(10H,m) 1 HNMR: (400MHz, CDCl 3 ) 1.28(3H, m), 1.80(3H, s), 2.96(1H, m), 4.24(1H, m), 4.56(1H, s), 5.90(1H, s) , 7.25-7.33 (10H, m)

实施例5:(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮(式(III)化合物)的制备Example 5: Preparation of (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone (compound of formula (III))

在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(II)化合物5.0g,氯代丁二酰亚胺4.1g,二氯甲烷150mL,水100mL。室温下光照搅拌反应过夜,有机相用5%亚硫酸氢钠洗涤后加入对甲苯磺酸10.0g,室温反应12小时,反应结束后蒸除溶剂,加入冷水200mL,过滤得到的滤液减压浓缩得到的粗品经硅胶柱层析得到化合物(III)1.9g,收率78.2%。In a 500 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 5.0 g of the compound of formula (II), 4.1 g of chlorosuccinimide, 150 mL of dichloromethane, and 100 mL of water. Stir the reaction at room temperature overnight, wash the organic phase with 5% sodium bisulfite, add 10.0 g of p-toluenesulfonic acid, react at room temperature for 12 hours, evaporate the solvent after the reaction, add 200 mL of cold water, and concentrate the obtained filtrate under reduced pressure to obtain The crude product was subjected to silica gel column chromatography to obtain 1.9 g of compound (III), with a yield of 78.2%.

MS:158(M+H)MS: 158(M+H)

1H-NMR:(400MHz,CDCl3)1.23(3H,s),1.77(3H,m),3.18(1H,m),3.65(1H,m),4.22(1H,s),4.30(1H,m),4.81(1H,s)。 1 H-NMR: (400MHz, CDCl 3 ) 1.23(3H, s), 1.77(3H, m), 3.18(1H, m), 3.65(1H, m), 4.22(1H, s), 4.30(1H, m), 4.81 (1H, s).

实施例6:(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮(式(III)化合物)的制备Example 6: Preparation of (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone (compound of formula (III))

在一装有磁力搅拌机、温度计的500mL四口圆底烧瓶中,加入式(II)化合物5.0g,溴代丁二酰亚胺3.0g,二氯甲烷150mL,水100mL。室温下光照搅拌反应过夜,有机相用5%亚硫酸氢钠洗涤后蒸除二氯甲烷,加入100mL四氢呋喃,加入硅胶10.0g,回流反应12小时,反应结束后过滤除去硅胶,用少量甲醇洗涤硅胶,合并滤液后蒸除四氢呋喃,加入水200mL,甲苯洗涤(3×100mL),分液,水相减压浓缩得到化合物(III)2.1g,收率86.4%。In a 500 mL four-neck round bottom flask equipped with a magnetic stirrer and a thermometer, add 5.0 g of the compound of formula (II), 3.0 g of bromosuccinimide, 150 mL of dichloromethane, and 100 mL of water. Stir the reaction under light at room temperature overnight, wash the organic phase with 5% sodium bisulfite, evaporate dichloromethane, add 100mL tetrahydrofuran, add 10.0g silica gel, reflux reaction for 12 hours, filter to remove silica gel after the reaction, wash the silica gel with a small amount of methanol After combining the filtrates, the tetrahydrofuran was distilled off, 200 mL of water was added, washed with toluene (3×100 mL), separated, and the aqueous phase was concentrated under reduced pressure to obtain 2.1 g of compound (III), with a yield of 86.4%.

MS:158(M+H)MS: 158(M+H)

1H-NMR:(400MHz,CDCl3)1.23(3H,s),1.77(3H,m),3.18(1H,m),3.65(1H,m),4.22(1H,s),4.30(1H,m),4.81(1H,s)。 1 H-NMR: (400MHz, CDCl 3 ) 1.23(3H, s), 1.77(3H, m), 3.18(1H, m), 3.65(1H, m), 4.22(1H, s), 4.30(1H, m), 4.81 (1H, s).

实施例7:(3S,4R)-3-((R)-1-羟基乙基)-4-乙酰氧基-2-氮杂环丁酮(式(VII)化合物)的制备Example 7: Preparation of (3S, 4R)-3-((R)-1-hydroxyethyl)-4-acetoxy-2-azetidinone (compound of formula (VII))

在一装有磁力搅拌机、温度计的500mL四口烧瓶中,加入式(III)化合物4.4g,间氯过氧苯甲酸12.0g,二氯甲烷200mL。室温搅拌过夜,反应结束后加入5%亚硫酸氢钠溶液洗涤,盐水洗涤,无水硫酸镁干燥,过滤蒸除溶剂硅胶柱层析得到化合物(VII)4.2g,收率87.5%。In a 500 mL four-necked flask equipped with a magnetic stirrer and a thermometer, add 4.4 g of the compound of formula (III), 12.0 g of m-chloroperoxybenzoic acid, and 200 mL of dichloromethane. Stir at room temperature overnight, add 5% sodium bisulfite solution to wash after the reaction, wash with brine, dry over anhydrous magnesium sulfate, filter and distill off the solvent by silica gel column chromatography to obtain 4.2 g of compound (VII), with a yield of 87.5%.

MS:196(M+Na),214(M+Na+H2O),228(M+Na+CH3OH)MS: 196(M+Na), 214(M+Na+ H2O ), 228(M+Na+ CH3OH )

实施例8:(3R,4R)-3-((R)-1-叔丁基二甲基硅氧乙基)-4-乙酰氧基-2-氮杂环丁酮(4-AA)的制备Example 8: (3R, 4R)-3-((R)-1-tert-butyldimethylsiloxyethyl)-4-acetoxy-2-azetidinone (4-AA) preparation

在一装有磁力搅拌机、温度计的500mL四口烧瓶中,加入式(VII)化合物4.2g,叔丁基二甲基氯硅烷15.8g,咪唑21.6g,DMF200mL。室温搅拌过夜,反应结束后加入乙酸乙酯200mL,盐水洗涤,无水硫酸镁干燥,过滤蒸除溶剂硅胶柱层析得到化合物(VII)6.4g,收率91.8%,mp 106~108℃,

Figure B2009100518202D0000091
(c=1.0,CHCl3)。In a 500 mL four-neck flask equipped with a magnetic stirrer and a thermometer, add 4.2 g of the compound of formula (VII), 15.8 g of tert-butyldimethylchlorosilane, 21.6 g of imidazole, and 200 mL of DMF. Stir overnight at room temperature. After the reaction, 200 mL of ethyl acetate was added, washed with brine, dried over anhydrous magnesium sulfate, filtered and evaporated to remove the solvent by silica gel column chromatography to obtain 6.4 g of compound (VII), yield 91.8%, mp 106-108 °C,
Figure B2009100518202D0000091
(c=1.0, CHCl3 ).

ESI-MS(m/z):310(M+H+Na),342(M+H+Na+CH3OH)ESI-MS(m/z): 310(M+H+Na), 342(M+H+Na+ CH3OH )

1H-NMR(CDCl3)δ:0.07(6H,s),0.87(9H,s),1.26(3H,m),2.10(3H,s),3.18(1H,m),4.22(1H,m),5.84(1H,m),6.47(1H,s) 1 H-NMR (CDCl 3 ) δ: 0.07 (6H, s), 0.87 (9H, s), 1.26 (3H, m), 2.10 (3H, s), 3.18 (1H, m), 4.22 (1H, m ), 5.84(1H, m), 6.47(1H, s)

Claims (17)

1.(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮,其结构式如式(III)所示。1. (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone, the structural formula of which is shown in formula (III).
Figure F2009100518202C0000011
Figure F2009100518202C0000011
2.一种用于合成权利要求1所述(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮的中间体化合物,其结构式如式(I)所示。2. an intermediate compound for synthesizing (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone described in claim 1, its The structural formula is shown in formula (I).
Figure F2009100518202C0000012
Figure F2009100518202C0000012
3.一种用于合成权利要求1所述(3S,4S)-4-乙酰基-3-((R)-1-羟基乙基)-2-氮杂环丁酮的中间体化合物,其结构式如式(II)所示。3. an intermediate compound for synthesizing (3S, 4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone according to claim 1, its The structural formula is shown in formula (II).
Figure F2009100518202C0000013
Figure F2009100518202C0000013
4.一种制备根据权利要求1所述的式(III)化合物的方法,其包括以下步骤:4. A method for preparing a compound of formula (III) according to claim 1, comprising the steps of: a)将式(IV)和式(V)所示化合物在酰氯活化下加入碱,在有机溶剂中进行缩合,得到式(I)化合物;a) adding a base to the compounds represented by formula (IV) and formula (V) under the activation of acid chloride, and condensing in an organic solvent to obtain the compound of formula (I);
Figure F2009100518202C0000014
Figure F2009100518202C0000014
b)使式(I)化合物在碱的催化下在有机溶剂中闭环,得到式(II)化合物;b) ring-closing the compound of formula (I) in an organic solvent under the catalysis of a base to obtain the compound of formula (II); c)使式(II)化合物在卤化剂、水和硅胶或者质子酸作用下在有机溶剂中脱除二苯甲基保护基,得到式(III)化合物。c) removing the benzhydryl protecting group from the compound of formula (II) in an organic solvent under the action of a halogenating agent, water, silica gel or protonic acid to obtain the compound of formula (III).
5.根据权利要求4所述的方法,其特征在于,5. The method of claim 4, wherein, 步骤a)中采用的酰氯选自一种或多种下列物质:乙酰氯、二氯亚砜、草酰氯、特戊酰氯、氯甲酸异丁酯、2,4,6-三氯苯甲酰氯;The acid chloride used in step a) is selected from one or more of the following substances: acetyl chloride, thionyl chloride, oxalyl chloride, pivaloyl chloride, isobutyl chloroformate, 2,4,6-trichlorobenzoyl chloride; 所述的碱选自一种或多种下列物质:DBU、二甲胺、二乙胺、二异丙胺、N-甲基苯胺、哌啶、吡咯、吡啶、吗啉、二异丙基乙胺、三乙胺、N,N-二甲基苯胺、N-乙基哌啶、N-甲基吗啉、N-乙基吡咯烷、N,N,N’N’-四甲基乙二胺;The base is selected from one or more of the following substances: DBU, dimethylamine, diethylamine, diisopropylamine, N-methylaniline, piperidine, pyrrole, pyridine, morpholine, diisopropylethylamine , triethylamine, N,N-dimethylaniline, N-ethylpiperidine, N-methylmorpholine, N-ethylpyrrolidine, N,N,N'N'-tetramethylethylenediamine ; 所述的溶剂选自一种或多种下列物质:卤代烃类、烷烃、酯类、乙醚,异丙醚、甲基叔丁基醚、四氢呋喃、苯、甲苯、二甲苯、乙腈。The solvent is selected from one or more of the following substances: halogenated hydrocarbons, alkanes, esters, diethyl ether, isopropyl ether, methyl tert-butyl ether, tetrahydrofuran, benzene, toluene, xylene, and acetonitrile. 6.根据权利要求5所述的方法,其特征在于,所述步骤a)中化合物(V)的用量是化合物(IV)的1~2倍,采用的酰氯用量是是化合物(IV)的1~2倍,碱的用量是化合物(IV)的1~5倍。6. The method according to claim 5, characterized in that, in the step a), the amount of compound (V) is 1 to 2 times that of compound (IV), and the amount of acid chloride used is 1 times that of compound (IV). ~2 times, the consumption of base is 1~5 times of compound (IV). 7.根据权利要求5所述的方法,其特征在于,所述步骤a)中采用的反应温度为-50℃~40℃。7. The method according to claim 5, characterized in that, the reaction temperature adopted in the step a) is -50°C to 40°C. 8.根据权利要求7所述的方法,其特征在于,所述步骤a)中采用的反应温度为-20~25℃。8. The method according to claim 7, characterized in that, the reaction temperature adopted in the step a) is -20-25°C. 9.根据权利要求4或5所述的方法,其特征在于,步骤b)中,9. The method according to claim 4 or 5, characterized in that, in step b), 所述的碱选自一种或多种下列物质:六甲基二硅胺锂、六甲基二硅胺钠、二异丙胺锂;The base is selected from one or more of the following substances: lithium hexamethyldisilazide, sodium hexamethyldisilazide, lithium diisopropylamide; 所述的溶剂选自一种或多种下列物质:卤代烃、烷烃、四氢呋喃、乙醚、异丙醚、甲基叔丁基醚、四氢呋喃、苯、甲苯、二甲苯、乙腈。The solvent is selected from one or more of the following substances: halogenated hydrocarbons, alkanes, tetrahydrofuran, diethyl ether, isopropyl ether, methyl tert-butyl ether, tetrahydrofuran, benzene, toluene, xylene, and acetonitrile. 10.根据权利要求9所述的方法,其特征在于,所述步骤b)中采用的碱用量是化合物(I)的1~2倍。10. The method according to claim 9, characterized in that the amount of alkali used in the step b) is 1 to 2 times that of compound (I). 11.根据权利要求9所述的方法,其特征在于,所述步骤b)中采用的反应温度是-20℃~40℃。11. The method according to claim 9, characterized in that, the reaction temperature adopted in the step b) is -20°C to 40°C. 12.根据权利要求11所述的方法,其特征在于,所述步骤b)中采用的反应温度是-20~25℃。12. The method according to claim 11, characterized in that, the reaction temperature adopted in the step b) is -20-25°C. 13.根据权利要求4或5所述的方法,其特征在于,步骤c)中,13. The method according to claim 4 or 5, characterized in that, in step c), 所述的卤化剂选自一种或多种下列物质:N-氯代丁二酰亚胺、N-溴代丁二酰亚胺;The halogenating agent is selected from one or more of the following substances: N-chlorosuccinimide, N-bromosuccinimide; 所述的溶剂选自一种或多种下列物质:脂肪酮、芳香酮、烷烃、卤代烷、乙腈、四氢呋喃、乙醚,异丙醚、甲基叔丁基醚、苯、甲苯、二甲苯;The solvent is selected from one or more of the following substances: aliphatic ketones, aromatic ketones, alkanes, haloalkanes, acetonitrile, tetrahydrofuran, ether, isopropyl ether, methyl tert-butyl ether, benzene, toluene, xylene; 反应采用硅胶或者质子酸进行脱保护The reaction uses silica gel or protic acid for deprotection 所述质子酸为能提供质子的无机酸或有机酸,其选自一种或多种下列酸:盐酸,硫酸,硝酸,磷酸,对甲苯磺酸,乙酸,甲酸。The protonic acid is an inorganic or organic acid capable of donating protons, which is selected from one or more of the following acids: hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, p-toluenesulfonic acid, acetic acid, formic acid. 14.根据权利要求13所述的方法,其特征在于,所述卤化剂为N-溴代丁二酰亚胺。14. The method according to claim 13, wherein the halogenating agent is N-bromosuccinimide. 15.根据权利要求4或5所述的方法,其特征在于,步骤c)中,所采用的卤化剂用量是式(II)化合物的1~2倍,硅胶或者质子酸的用量是式(II)化合物的1~5倍。15. The method according to claim 4 or 5, characterized in that, in step c), the amount of the halogenating agent used is 1 to 2 times that of the compound of formula (II), and the amount of silica gel or protonic acid is the amount of formula (II) ) compound 1 to 5 times. 16.根据权利要求4或5所述的方法,其特征在于,步骤c)中,所采用的反应温度为0℃~100℃。16. The method according to claim 4 or 5, characterized in that, in step c), the reaction temperature used is 0°C-100°C. 17.根据权利要求16所述的方法,其特征在于,步骤c)中,所采用的反应温度为20~80℃。17. The method according to claim 16, characterized in that, in step c), the reaction temperature used is 20-80°C.
CN 200910051820 2009-05-22 2009-05-22 (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method Expired - Fee Related CN101891665B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200910051820 CN101891665B (en) 2009-05-22 2009-05-22 (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200910051820 CN101891665B (en) 2009-05-22 2009-05-22 (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method

Publications (2)

Publication Number Publication Date
CN101891665A true CN101891665A (en) 2010-11-24
CN101891665B CN101891665B (en) 2013-02-06

Family

ID=43101040

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200910051820 Expired - Fee Related CN101891665B (en) 2009-05-22 2009-05-22 (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method

Country Status (1)

Country Link
CN (1) CN101891665B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103665021A (en) * 2013-12-03 2014-03-26 西安赛美科医药研发有限公司 Synthetic method of biapenem drug intermediate 4-AA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003277390A (en) * 2002-03-25 2003-10-02 Takasago Internatl Corp Method for producing azetidinone compound
CN101367831B (en) * 2008-09-28 2011-12-07 重庆大学 Midbody for preparing carbpenem antibiotics and method of preparing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103665021A (en) * 2013-12-03 2014-03-26 西安赛美科医药研发有限公司 Synthetic method of biapenem drug intermediate 4-AA

Also Published As

Publication number Publication date
CN101891665B (en) 2013-02-06

Similar Documents

Publication Publication Date Title
CN111925381B (en) A kind of synthetic method of baloxavir key intermediate
CN103113308A (en) Method for preparing dihydropyrimidinone derivative
CN103910657A (en) Ring opening method of aziridine compounds
CN105148988B (en) A kind of chiral pyridoxal class catalyst and its synthetic method and application
CN105873904B (en) The manufacture method of 2 amino-nicotinic acid benzyl derivatives
CN106188073A (en) A kind of ecteinascidin 743 Alkaloid intermediate and its preparation method and application
CN101891665A (en) (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method
WO2021045879A1 (en) Synthesis of deuterated aldehydes
CN103709101B (en) Synthetic intermediate of one class renieramycin G and preparation method thereof
CN101121692A (en) Synthetic method of α-carbonyl amides
CN103382162B (en) Preparation method of acylazido compound
ES2312162T3 (en) PROCEDURE FOR OBTAINING A SALT OF VALSARTAN USEFUL FOR THE PREPARATION OF VALSARTAN.
CN105801538B (en) A kind of method for preparing 2,3- dihydro-benzofuran derivatives
CN109879832B (en) A kind of 4-alkoxy-2-arylmercaptomorpholine-3,5-dione compound and preparation method thereof
KR101071440B1 (en) USAGE OF POLY-3-HYDROXYBUTYRATES IN PREPARATION OF β-LACTAM COMPOUNDS
CN110590641B (en) A kind of green preparation method of 3-hydroxyisoindol-1-one series compounds
JP4899385B2 (en) Method for producing 3-aminomethyloxetane compound
CN118459375A (en) A method for preparing N-sulfonyl amidine compound
JPWO2002076958A1 (en) Method for producing 5-substituted oxazole compound and 5-substituted imidazole compound
CN101177416B (en) (2'S,3'R,4S)-3-[2'-(N-substituted aminomethyl)-3'-hydroxy butyryl]-4-substituted oxazolidin-2-ketone derivative and preparation method thereof
CN104974101A (en) Synthesis method of triazole-olefin compound
CN119735513A (en) Synthesis method of unprotected 1, 2-amino ester and oxazoline derivative
CN105294517A (en) Method for preparing chiral 1, 3-diamine
CN102153432B (en) A kind of preparation method of α-trifluoromethyl-γ-carbonyl ester
CN102718695B (en) Method for synthesizing aza-bicyclo octane [3.3.0] derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130206

Termination date: 20180522